Sign Up To Be Notified About Future Clinical Trials

Hemostemix plans to continue to field new clinical trials that study ACP-01 across several conditions. If you would like us to notify you when a new study is being fielded, please fill out the information below.

At this time we will not be asking for any personal health information (PHI). Study qualifications will be discussed with patients when the study is approved to begin recruitment.